Intellia Therapeutics Inc (NASDAQ:NTLA)

46.08
Delayed Data
As of Dec 02
 +0.28 / +0.61%
Today’s Change
37.08
Today|||52-Week Range
130.33
-61.03%
Year-to-Date

Stock Price Forecast

The 25 analysts offering 12-month price forecasts for Intellia Therapeutics Inc have a median target of 115.00, with a high estimate of 173.00 and a low estimate of 48.00. The median estimate represents a +149.57% increase from the last price of 46.08.

Analyst Recommendations

The current consensus among 28 polled investment analysts is to Buy stock in Intellia Therapeutics Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.37
Sales
$11.2M
Reporting Date
Mar 15

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 7.99%
 
 
 
 
 
 
Growthannually -61.79%
 
 
 
 
 
 

Sales

Growthquarterly -15.86%
 
 
 
 
 
 
Growthannually 56.85%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.